Biggest Manufacturer，Idasanutlin KK-20（1229705-06-9） and Intermediates.

EOS med chem is the only manufacturer that provides excellent quality chemistry products and services at affordable rates. The experts working here are highly trained to handle these chemicals used in the creation of medicines used for treating various life-threatening diseases. We are into the manufacturing of chemical products after doing a deep research for the same.

EOS team of experts holds the work experience of more than ten years, and therefore we can assure you about the quality and superiority of the products and services we offer to all our valued clients around the globe. At present, this organization is listed among the most leading pharmaceutical suppliers around the world. We always supply products keeping the affordability in mind.

  2018 Korea CPHI, C30

EOS Med Chem, Medchem is Big
執大象，天下往，往而無害，安平泰
WEB: www.eosmedchem.com
EMAIL: info@eosmedchem.com; eosmedchem@gmail.com; eosmedchem@qq.com  TEL: 0086-531-69905422
GMP PLANT: No. 37, Yulong Road, Qufu City, Shandong Province.

1.

Idasanutlin KK-20, CAS#1229705-06-9, HNMR, HPLC 99%+, LCMS, COA, MSDS and ROS, more than 54KG in stock, pls check:

Name:Idasanutlin KK-20

CAS#: 1229705-06-9

Formula: C31H29Cl2F2N3O4 

Exact Mass: 615.15032 

Molecular Weight: 616.48247 

Elemental Analysis: C, 60.40; H, 4.74; Cl, 11.50; F, 6.16; N, 6.82; O, 10.38

Appearance: white solid powder

Purity: >98% (or refer to the Certificate of Analysis)

2. 

Idasanutlin KK-20Intermediates:

1. Idasanutlin KK-20 Intermediate:3-(3-Chloro-2-fluorophenyl)-2-(4-chloro-2-fluorophenyl)acrylonitrile,

Cas#1219086-87-9

We have more than 65kg in stock, assay 99% in GMP plant, C-GMP standard, 

now COA, NMR, HPLC, MS is ok.

2. Idasanutlin KK-20 Intermediate:Ethyl 4-(2-((3,3-dimethylbutylidene)amino)acetamido)-3-methoxybenzoate

Cas#2034194-92-6

We have more than 68kg in stock, assay 99% in GMP plant, C-GMP standard, 

now COA, NMR, HPLC, MS is ok.

Reference：

1: Ding Q, Zhang Z, Liu JJ, Jiang N, Zhang J, Ross TM, Chu XJ, Bartkovitz D, Podlaski F, Janson C, Tovar C, Filipovic ZM, Higgins B, Glenn K, Packman K, Vassilev LT, Graves B. Discovery of RG7388, a Potent and Selective p53-MDM2 Inhibitor in Clinical Development. J Med Chem. 2013, 56 (14), 5979–5983.

PubMed PMID: 23808545.